• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Zinc finger protein 202 (ZNF202)

ACP20839

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP20839 Target NameZNF202
Target SynonymsZNF202; ZKSCAN10; Zinc finger protein 202; Zinc finger protein with KRAB and SCAN domains 10FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-648
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDO95125
Background Information
  • Uniprot Id

    O95125

  • Target Species

    Human

  • Target Name

    ZNF202

  • Target Full Name

    Zinc finger protein 202

  • Target Function

    Transcriptional repressor that binds to elements found predominantly in genes that participate in lipid metabolism. Among its targets are structural components of lipoprotein particles (apolipoproteins AIV, CIII, and E), enzymes involved in lipid processing (lipoprotein lipase, lecithin cholesteryl ester transferase), transporters involved in lipid homeostasis (ABCA1, ABCG1), and several genes involved in processes related to energy metabolism and vascular disease.

  • Target Subcellular Location

    Nucleus.

  • Target Tissue Specificity

    Highly expressed in testis. Also expressed in breast carcinoma cell lines.

  • Target Synonyms

    ZNF202; ZKSCAN10; Zinc finger protein 202; Zinc finger protein with KRAB and SCAN domains 10

Inquire Recombinant Human Zinc finger protein 202 (ZNF202) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification